Background and objectives: Trigeminal neuralgia is an extremely painful condition characterized by recurrent episodes of sudden, lancinating, shock-like pain lasting from a few seconds to two minutes usually unilateral. It has an annual incidence of approximately 4.3 in 100,000 in the general population and only 3% of those cases present bilateral manifestation. The objective of this report was to describe a rare case of bilateral trigeminal neuralgia.
Case report: A 61 years old housewife from Maranhão, Brazil, married, with a history of hypertension, presented with a six-year history of severe pain in the left V2-V3 regions, lasting 5 to 10 seconds, in the lateral aspect of the nose and mandible, worsening by talking, chewing, and with a decrease in temperature. She had been treated with chlorpromazine (3 mg every eight hours) and carbamazepine (200 mg every eight hours) during six months without improvement. On physical exam, the patient presented thermal and mechanical allodynia in the V2-V3 regions. She was using gabapentin (1,200 mg/day) with partial relief of the pain. The dose of gabapentin was increased to 1,500 mg/day and amitriptyline 12.5 mg at night was added to the therapeutic regimen. The patient evolved with mild and sporadical pain and a reduction in pain severity during 10 months; the dose of gabapentin was progressively reduced to 600 mg/day, and amitriptyline was maintained at 12.5 mg/day. After one year, the patient developed similar pain in the region of the right mandible, which improved with an increase in the dose of gabapentin to 900 mg/day. Head CT and MRI did not show any abnormalities.
Conclusions: Carbamazepine is the first choice for the treatment of trigeminal neuralgia; however, the use of gabapentin as the first pharmacological choice or in cases refractory to conventional therapy has been increasing.
Krafft RM. Krafft RM. Am Fam Physician. 2008 May 1;77(9):1291-6. Am Fam Physician. 2008. PMID: 18540495 Review.
Pandey CK, Singh N, Singh PK. Pandey CK, et al. J Indian Med Assoc. 2008 Feb;106(2):124-5. J Indian Med Assoc. 2008. PMID: 18705259
Siniscalchi A, Gallelli L, Avenoso T, Squillace A, De Sarro G. Siniscalchi A, et al. Ann Pharmacother. 2011 Jun;45(6):e33. doi: 10.1345/aph.1Q013. Epub 2011 Jun 7. Ann Pharmacother. 2011. PMID: 21652789
Rozen TD. Rozen TD. Headache. 2001 Nov-Dec;41 Suppl 1:S25-32. doi: 10.1046/j.1526-4610.2001.01154-5.x. Headache. 2001. PMID: 11903537 Review.
Baker KA, Taylor JW, Lilly GE. Baker KA, et al. Clin Pharm. 1985 Jan-Feb;4(1):93-6. Clin Pharm. 1985. PMID: 3971692
Shinde S, Lohe V, Mohod S, Dadgal KV, Shirbhate U, Solanki D. Shinde S, et al. Cureus. 2024 Feb 17;16(2):e54347. doi: 10.7759/cureus.54347. eCollection 2024 Feb. Cureus. 2024. PMID: 38505464 Free PMC article.
Yadav YR, Nishtha Y, Sonjjay P, Vijay P, Shailendra R, Yatin K. Yadav YR, et al. Asian J Neurosurg. 2017 Oct-Dec;12(4):585-597. doi: 10.4103/ajns.AJNS_67_14. Asian J Neurosurg. 2017. PMID: 29114270 Free PMC article. Review.
Agrawal SM, Kambalimath DH. Agrawal SM, et al. Natl J Maxillofac Surg. 2010 Jul;1(2):179-82. doi: 10.4103/0975-5950.79226. Natl J Maxillofac Surg. 2010. PMID: 22442595 Free PMC article.